Article

Adoptive In Situ Vaccination with Cyclical Intermittent Stereotactic Body Radiotherapy (SBRT) and Immunotherapy – a Review and Proposed Strategy

2023-10-03

Abstract excerpt

Immunotherapy with stereotactic body radiotherapy (SBRT), low-dose antiangiogenics, immune adjuvants, nanomedicine, or other combinations will likely play a lead role in managing malignancies soon. Presently, its benefit extends to about 12% to 20% of patients, in the background of possible recurrence eventually and the toxicities, including in non-responders. Stereotactic body radiotherapy (SBRT) not only elimina...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a3340b86-26d8-57cd-b2a7-9da1d221e019
DOI: 10.20944/preprints202308.0648.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Adoptive In Situ Vaccination with Cyclical Intermittent Stereotactic Body Radiotherapy (SBRT) and Immunotherapy – a Review and Proposed StrategyDOI 10.20944/preprints202308.0648.v2Read

Radiation‐Induced Immunogenic Cell Death for Cancer RadioimmunotherapySemantic proximity Read

Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor modelSemantic proximity Read

Antitumor immune responses induced by ionizing irradiation and further immune stimulation.Semantic proximity Read

Reduced irradiation exposure areas enhanced anti-tumor effect by inducing DNA damage and preserving lymphocytesSemantic proximity Read

Mechanistic in silico explorations of the immunogenic and synergistic effects of radiotherapy and immunotherapy: a critical reviewSemantic proximity Read

Spatially Fractionated GRID radiation potentiates immune-mediated tumor controlSemantic proximity Read

In situ vaccine effect of radiotherapy is associated with intratumoural ERV transcription and RNA virus sensingSemantic proximity Read

Turning anecdotal irradiation-induced anti-cancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cellsSemantic proximity Read

In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.Semantic proximity Read

Boosting the Immune Response – Combining the Local and Immune Therapy for Prostate Cancer TreatmentSemantic proximity Read

Stereotactic Core Ablative Radiation Therapy (SCART) - principal and practice of a novel strategy to treat bulky tumorSemantic proximity Read

Radio-immune response modelling for spatially fractionated radiotherapySemantic proximity Read